Parathyroid Clinical Trials

2 recruiting

Frequently Asked Questions

Common questions about Parathyroid clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 55 trials

Recruiting

Natural History Study of Parathyroid Disorders

Primary HyperparathyroidismParathyroid CancerPseudohypoparathyroidism+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3,000 enrolled1 locationNCT04969926
Recruiting

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

Endocrine TumorsNeuroblastomaThyroid Neoplasms+2 more
National Cancer Institute (NCI)2,415 enrolled1 locationNCT01005654
Recruiting
Early Phase 1

Efficacy and Safety of XH02 for the Treatment of Hypoparathyroidism

Hypoparathyroidism
Peking Union Medical College Hospital6 enrolled1 locationNCT07197450
Recruiting
Phase 3

A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis

Secondary Hyperparathyroidism
Amgen24 enrolled23 locationsNCT03969329
Recruiting
Not Applicable

PRESS -PAR: Early Detection and PREvention of Symptomatic postSurgical hypoPARathyroidism After Thyroid Surgery"

Hypoparathyroidism Post-surgicalPostoperative HypoparathyroidismPostsurgical Hypoparathyroidism
Nicolas Schlegel336 enrolled1 locationNCT07491601
Recruiting
Not Applicable

Patient Navigation to Improve Surgical Access in Primary Hyperparathyroidism

Hyperparathyroidism, Primary
University of Pennsylvania76 enrolled1 locationNCT06562881
Recruiting

A Global Pregnancy Registry to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to YORVIPATH® (Palopegteriparatide) During Pregnancy and Breastfeeding

Hypoparathyroidism
Ascendis Pharma A/S50 enrolled1 locationNCT07345494
Recruiting
Phase 3

A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

Chronic Kidney DiseaseSecondary Hyperparathyroidism
Amgen56 enrolled43 locationsNCT03633708
Recruiting
Phase 1Phase 2

Parathyroid Allotransplant for Treatment of Hypoparathyroidism

HypoparathyroidismHypoparathyroidism Post-surgicalHypoparathyroidism Postprocedural
Peter Stock3 enrolled1 locationNCT06961071
Recruiting
Not Applicable

Parathyroidectomy After Kidney Transplantation

HyperparathyroidismKidney Transplantation Recipients
Aarhus University Hospital85 enrolled1 locationNCT07415421
Recruiting
Not Applicable

Comparing PTeye-assisted Versus Conventional Total Thyroidectomy

Total ThyroidectomyHypocalcemiaHypoparathyroidism Post-surgical+1 more
The University of Hong Kong210 enrolled1 locationNCT07416149
Recruiting

IDMet (RaDiCo Cohort) (RaDiCo-IDMet)

Beckwith-Wiedemann SyndromePrader-Willi SyndromePseudohypoparathyroidism+6 more
Institut National de la Santé Et de la Recherche Médicale, France2,000 enrolled20 locationsNCT05945576
Recruiting

Amino Acid Transporter System PET/CT Imaging in AATS-Related Diseases

GliomaPrimary HyperparathyroidismAmino-Acid Transport Disorder
Tianjin Medical University500 enrolled2 locationsNCT07379463
Recruiting
Phase 1

A Mass Balance Study of [14C] MT1013 in Hemodialysis Subjects With Secondary Hyperparathyroidism

Hemodialysis Subjects With Secondary Hyperparathyroidism
Shaanxi Micot Pharmaceutical Technology Co., Ltd.6 enrolled1 locationNCT07284043
Recruiting

Hypoparathyroidism Natural History Study

Hypoparathyroidism
Columbia University106 enrolled1 locationNCT05793853
Recruiting

Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors

Primary HyperparathyroidismParathyroid Gland CarcinomaParathyroid Gland Atypical Adenoma+1 more
M.D. Anderson Cancer Center310 enrolled1 locationNCT03039439
Recruiting

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

Heart FailureSarcopeniaOsteoporosis+11 more
Bettina Mittendorfer100 enrolled1 locationNCT07083557
Recruiting
Phase 3

Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism

Secondary Hyperparathyroidism, Chronic Kidney Disease
Shaanxi Micot Pharmaceutical Technology Co., Ltd.424 enrolled1 locationNCT07122401
Recruiting

Parathyroidectomy and Mobility Study

MobilityHyperparathyroidismParathyroid
University of Florida80 enrolled1 locationNCT07103876
Recruiting
Phase 4

Sore Throat After Open Neck Elective Surgery

Postoperative Sore Throat, Cough, HoarsenessThyroid and Parathyroid Surgery
Saint Petersburg State University, Russia764 enrolled1 locationNCT07124650